Empagliflozin 10 mg + Linagliptin 5 mg Tablet – Brands in India, Manufacturer & PCD Franchise (Emparon-L 10/5)



Empagliflozin 10 mg + Linagliptin 5 mg Tablet — made for Trumac Healthcare at WHO-GMP certified partner units

Empagliflozin 10 mg + Linagliptin 5 mg Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Empagliflozin 10 mg + Linagliptin 5 mg
Form: Tablet
Class: SGLT2 inhibitor (with combination partner if applicable)
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Empagliflozin 10 mg + Linagliptin 5 mg Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Empagliflozin 10 mg + Linagliptin 5 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Emparon-L 10/5 Tablet

Emparon-L 10/5 Tablet

Pack: 10 x 10 (Bliser)

MRP: ₹2200

View Emparon-L 10/5 Tablet →

Empagliflozin 10 mg + Linagliptin 5 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Empagliflozin 10 mg + Linagliptin 5 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the general range products product list. No franchise fee; minimum first order ₹25,000 – cost and documents.


Empagliflozin + linagliptin Brands in India – Emparon-L 10/5 for PCD Franchise & Wholesale

Looking for empagliflozin + linagliptin brands in India? Trumac Healthcare markets empagliflozin + linagliptin as Emparon-L 10/5, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. An SGLT2 inhibitor and a DPP-4 inhibitor in one once-daily tablet; the 25/5 strength is the step-up.

It is part of the cardiac-diabetic PCD franchise (Ecron Life Sciences) range. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.

Related brands

Ways to work with us

  • PCD pharma franchise – empagliflozin + linagliptin under our brand on a monopoly basis for your area, with visual aids and promotional material
  • Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
  • Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation

How to start

  1. Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
  2. Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
  3. Confirm the order and pay by NEFT, RTGS or IMPS
  4. Goods are dispatched once payment reflects, with the docket number for tracking

Questions buyers ask

Which empagliflozin + linagliptin brands are available in India for PCD franchise?

Emparon-L 10/5 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.

Do you supply empagliflozin + linagliptin wholesale?

Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.

Which division is it part of?

The cardiac-diabetic (Ecron Life Sciences) division, which can be taken alone on monopoly for your district.

Can I get empagliflozin + linagliptin under my own brand?

Share your brand name, pack and quantity on WhatsApp and we will confirm availability and send a quotation.

Enquiry: Share your empagliflozin + linagliptin requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.

Therapeutic Indications
  • Type-2 diabetes mellitus inadequately controlled by lifestyle measures or other oral agents
  • Cardiovascular risk reduction in type-2 DM with established CV disease
  • Heart failure with reduced or preserved ejection fraction
  • Chronic kidney disease (CKD) protection in diabetic and non-diabetic patients
Mechanism of Action

Empagliflozin selectively inhibits SGLT2 in the proximal renal tubule, reducing glucose reabsorption and increasing urinary glucose excretion (about 70 g/day). The osmotic diuresis also reduces blood pressure and pre-load, contributing to its heart-failure and renoprotective benefits.

Dosage & Administration
  • Take 1 tablet once daily in the morning, with or without food
  • Swallow whole with water
  • Ensure adequate hydration
  • Use under physician supervision
Side Effects
  • Genital mycotic infections (vulvovaginal candidiasis, balanitis)
  • Urinary tract infections
  • Polyuria and mild volume depletion
  • Hypoglycaemia (mainly when combined with sulphonylureas or insulin)
  • Diabetic ketoacidosis (rare; avoid with very low-carb diets, surgery)
Contraindications
  • Type-1 diabetes
  • History of diabetic ketoacidosis
  • eGFR < 30 mL/min/1.73 m² (use restrictions vary)
  • Pregnancy and breastfeeding
  • Active urogenital infection
Storage

Store below 25°C.

PCD Pharma Franchise for Empagliflozin 10 mg + Linagliptin 5 mg Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 10 (Bliser)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Empagliflozin 10 mg + Linagliptin 5 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Empagliflozin 10 mg + Linagliptin 5 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Empagliflozin 10 mg + Linagliptin 5 mg Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Empagliflozin 10 mg + Linagliptin 5 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Empagliflozin 10 mg + Linagliptin 5 mg Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Empagliflozin 10 mg + Linagliptin 5 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Empagliflozin 10 mg + Linagliptin 5 mg Tablet?

Available pack sizes include: 10 x 10 (Bliser).

What is the MRP / trade price for Empagliflozin 10 mg + Linagliptin 5 mg Tablet?

MRPs range from ₹2200 to ₹2200 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Empagliflozin 10 mg + Linagliptin 5 mg Tablet?

Get Pricing & Franchise Terms →